Background: This study characterizes the age of onset of schizophrenia spectrum disorders and summarizes findings regarding a range of clinical and social outcomes, cognition, brain structure, and mortality. Methods: The review is based on series of systematic and nonsystematic literature searches. We included original articles and systematic reviews looking associations between age of onset and incidence, risk factors, suicides, brain structure and cognition. Results: The peak age of onset for schizophrenia spectrum disorders is between 20 to 29 years, in where the incidence estimate was among males 4.15 and among females 1.71 per 10,000 person-years. Male gender has been linked with earlier onset age, although among those with family history and cannabis use corresponding gender difference do not exist. Early onset schizophrenia has been linked e.g. with higher familial risk, poor premorbid social adjustment and cannabis use. In adult samples, earlier age of onset associated with worse outcome, regarding hospitalisations, negative symptoms, relapses, social and occupational functioning, and global outcome. Also in childhood and adolescence schizophrenia, earlier onset has been linked with more severe outcomes. Early age of onset has been linked also with larger cognitive deficits and brain alterations. In the few existing studies, later AOO has been linked with a higher suicide rate. In all, the current study found various differences between patients with different age of onset. However, the studies on age of onset are relative heterogeneous on methodology and have given varying results. More good quality studies are needed including patients without restriction due to the onset age. Discussion: Age of onset is an important characteristic of schizophrenia that could help when examining the origin, genetic mechanism and care of schizophrenia. Understanding factors that influence age of onset in schizophrenia may offer clues to prevent or delay the onset of this debilitating group of disorders.
F129. COMBINED PATTERNS OF TOBACCO AND CANNABIS USE IN ADOLESCENCE AND THEIR ASSOCIATION WITH PSYCHOTIC EXPERIENCES: A LONGITUDINAL ANALYSIS
Background: There has been increasing concern about potentially causal effects of tobacco use on psychosis, but epidemiological studies have been less robust in attempts to minimise effects of confounding than studies of cannabis use have been. We therefore aim to examine the association of patterns of cigarette and cannabis use with preceding and subsequent psychotic experiences, and compare patterns of confounding across these patterns. Methods: We analysed repeated measures of cigarette and cannabis use during adolescence in a sample of 5,300 individuals in the Avon Longitudinal Study of Parents and Children birth cohort who had at least 3 measures of cigarette and cannabis use between ages 14-19 years. Cigarette and cannabis use data were summarised using longitudinal latent class analysis to identify longitudinal classes of substance use, and associations between classes and psychotic experiences at 18 years were assessed. Results: Prior to adjusting for a range of potential confounders, there was strong evidence that early-onset cigarette-only use (4.3%), early-onset cannabis use (3.2%), and late-onset cannabis use (11.9%), but not later-onset cigarette-only use (14.8%) latent classes were associated with increased psychotic experiences compared to non-users (65.9%) (omnibus P<0.001). After adjusting for confounders, the association for early-onset cigaretteonly use attenuated substantially (unadjusted odds ratio (OR) = 3.03, 95%CI 1.13, 8.14; adjusted OR = 1.78, 95%CI 0.54, 5.88), whereas those for early-onset (adjusted OR = 3.70, 95%CI 
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Background: Childhood adversities such as childhood abuse, bullying victimisation, and parental separation have been found to be associated with many psychiatric illnesses, including psychosis. A large body of research has been conducted on individuals at ultra-high risk (UHR) for psychosis, or clinical high risk (CHR)
